Accounting for All Costs in the Total Cost of Chimeric Antigen Receptor T-Cell Immunotherapy
- PMID: 30325984
- DOI: 10.1001/jamaoncol.2018.4625
Accounting for All Costs in the Total Cost of Chimeric Antigen Receptor T-Cell Immunotherapy
Comment in
-
Accounting for All Costs in the Total Cost of Chimeric Antigen Receptor T-Cell Immunotherapy-Reply.JAMA Oncol. 2018 Dec 1;4(12):1785-1786. doi: 10.1001/jamaoncol.2018.4657. JAMA Oncol. 2018. PMID: 30325998 No abstract available.
Comment on
-
Total Costs of Chimeric Antigen Receptor T-Cell Immunotherapy.JAMA Oncol. 2018 Jul 1;4(7):994-996. doi: 10.1001/jamaoncol.2018.0977. JAMA Oncol. 2018. PMID: 29710129 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources